In patients with advanced melanoma, the populations of CD14+ and CD14− MDSCs in peripheral blood are significantly increased compared to healthy donors, and the frequency of MDSCs is significantly correlated with the frequency of Tregs, indicating a significant increase and interrelation of immunosuppressive cells in patients with advanced melanoma (correlation between MDSCs and Tregs) (11). This evidence concerns the gene CD14 and melanoma.